The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Open accessAbstract
The current global health threat by the novel coronavirus disease 2019 (COVID-19) requires an urgent deployment of advanced therapeutic options available. The role of nanotechnology is highly relevant to counter this "virus" nano enemy. Nano intervention is discussed in terms of designing effective nanocarriers to counter the conventional limitations of antiviral and biological therapeutics. This strategy directs the safe and effective delivery of available therapeutic options using engineered nanocarriers, blocking the initial interactions of viral spike glycoprotein with host cell surface receptors, and disruption of virion construction. Controlling and eliminating the spread and reoccurrence of this pandemic demands a safe and effective vaccine strategy. Nanocarriers have potential to design risk-free and effective immunization strategies for severe acute respiratory syndrome coronavirus 2 vaccine candidates such as protein constructs and nucleic acids. We discuss recent as well as ongoing nanotechnology-based therapeutic and prophylactic strategies to fight against this pandemic, outlining the key areas for nanoscientists to step in.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–262 of 262
Ghamdi, M. A. A., Al-Ghamdi, K. M. G., Ghandoora, Y. M., Alzahrani, A., Salah, F., Alsulami, A., Bawayan, M. F., Vaidya, D. M., Perl, T. M., & Sood, G. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1492-4 · Cited by 159
Inhibition of SARS-CoV replication by siRNA
Wu, C., Huang, H.-W., Liu, C.-Y., Hong, C.-F., & Chan, Y.-L. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.09.005 · Cited by 153
Li, Y., Wan, Y., Liu, P., Zhao, J., Lu, G., Qi, J., Wang, Q., Lu, X., Wu, Y., Liu, W., et al. (2015) · Cell Research · doi:10.1038/cr.2015.113 · Cited by 150
Wang, H., Lu, Z., Wang, L., Guo, T., Wu, J., Wan, J., Zhou, L., Li, H., Li, Z., Jiang, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0984 · Cited by 150
Mesenchymal stem cells and management of COVID-19 pneumonia
Metcalfe, S. M. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100019 · Cited by 150
AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., He, F., Wu, T., Fang, M., Niu, Z., Wu, Z., & Xu, D. H. (2022) · Biomolecules · doi:10.3390/biom12060746 · Cited by 148
Chemical and structural modifications of RNAi therapeutics
Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K., & Kim, S. H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.015 · Cited by 147
Wang, C., Zheng, X., Gai, W., Zhao, Y., Wang, H., Wang, H., Feng, N., Chi, H., Qiu, B., Li, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8475 · Cited by 145
Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases
Rao, L., Tian, R., & Chen, X. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01665 · Cited by 143
Chen, I.-Y., Chang, S. C., Wu, H.-Y., Yu, T.-C., Wei, W.-C., Lin, S., Chien, C.-L., & Chang, M.-F. (2010) · Journal of Virology · doi:10.1128/jvi.02560-09 · Cited by 141
Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
Park, Y.-M., Lee, S. J., Kim, Y. S., Lee, M. H., Cha, G. S., Jung, I. D., Kang, T. H., & Han, H. D. (2013) · Immune Network · doi:10.4110/in.2013.13.5.177 · Cited by 138
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
Zhao, Y., Fay, F., Hak, S., Perez‐Aguilar, J. M., Sánchez-Gaytán, B. L., Brandon, G., Duivenvoorden, R., Davies, C. D. L., Bjørkøy, A., Weinstein, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11221 · Cited by 138
Sokolova, V., Knuschke, T., Kovtun, A., Buer, J., Epple, M., & Westendorf, A. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.067 · Cited by 136
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02377-07 · Cited by 134
Multi-drug delivery nanocarriers for combination therapy
Gadde, S. (2015) · MedChemComm · doi:10.1039/c5md00365b · Cited by 132
CoViD-19 Immunopathology & Immunotherapy
Chiappelli, F., Khakshooy, A., & Greenberg, G. (2020) · Bioinformation · doi:10.6026/97320630016219 · Cited by 132
Geng, Y., Wei, Z.-Y., Qian, H., Huang, J., Lodato, R. F., & Castriotta, R. J. (2020) · Cardiovascular Pathology · doi:10.1016/j.carpath.2020.107228 · Cited by 132
Nanoparticle formulated vaccines: opportunities and challenges
Lung, P., Yang, J., & Li, Q. (2020) · Nanoscale · doi:10.1039/c9nr08958f · Cited by 131
Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E., van der Vlies, A. J., McKinney, J. D., Hubbell, J. A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.039 · Cited by 130
Engineering complement activation on polypropylene sulfide vaccine nanoparticles
Thomas, S. N., van der Vlies, A. J., O’Neil, C. P., Reddy, S. T., Yu, S. S., Giorgio, T. D., Swartz, M. A., & Hubbell, J. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.037 · Cited by 127
Turley, D. M., & Miller, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2212 · Cited by 126
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry
Lauster, D. C., Klenk, S., Ludwig, K., Nojoumi, S., Behren, S., Adam, L., Stadtmüller, M., Saenger, S., Zimmler, S., Hönzke, K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0660-2 · Cited by 126
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
Lim, M., Badruddoza, A. Z. M., Firdous, J., Azad, M. A., Mannan, A., Al-Hilal, T. A., Cho, C., & Islam, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010030 · Cited by 121
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Zhou, Y., Yang, Y., Huang, J., Jiang, S., & Du, L. (2019) · Viruses · doi:10.3390/v11010060 · Cited by 120
He, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118
Time to use the p-word? Coronavirus enters dangerous new phase
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-00551-1 · Cited by 117
Rivière, G., Michaud, A., Breton, C., Camp, G. V., Laborie, C., Enache, M., Lésage, J., DELOOF, S., Corvol, P. L., & Vieau, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000185148.27901.fe · Cited by 115
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Destache, C. J., Belgum, T., Christensen, K. J., Shibata, A., Sharma, A. D., & Dash, A. K. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-198 · Cited by 115
A year-long extended release nanoformulated cabotegravir prodrug
Kulkarni, T. A., Bade, A. N., Sillman, B., Shetty, B. L. D., Wojtkiewicz, M. S., Gautam, N., Hilaire, J. R., Sravanam, S., Szlachetka, A. M., Lamberty, B. G., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0674-z · Cited by 115
Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 109
LaBauve, A. E., Rinker, T. E., Noureddine, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32033-w · Cited by 109
Lin, S., Lin, S., Hsu, J.-N., Chang, C., Chien, C., Wang, Y., Wu, H., Jeng, U., Kehn‐Hall, K., & Hou, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01913 · Cited by 109
Hu, Q., Rijcken, C. J. F., Bansal, R., Hennink, W. E., Storm, G., & Prakash, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.085 · Cited by 106
Nicholson, K. G., Abrams, K. R., Batham, S., Clark, T. W., Höschler, K., Lim, W. S., Medina, M. J., Nguyen‐Van‐Tam, J. S., Read, R. C., Warren, F. C., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70296-6 · Cited by 95
Shima, F., Akagi, T., Uto, T., & Akashi, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.064 · Cited by 95
Autonomous phagosomal degradation and antigen presentation in dendritic cells
Hoffmann, E., Kotsias, F., Visentin, G., Bruhns, P., Savina, A., & Amigorena, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203912109 · Cited by 92
Adjuvant strategies to improve vaccination of the elderly population
Weinberger, B. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.03.014 · Cited by 92
Gold nanoparticles and vaccine development
Salazar-González, J. A., González‐Ortega, O., & Rosales‐Mendoza, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1064772 · Cited by 87
MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation ofSMAD4
Xia, X., Zhang, K., Cen, G., Jiang, T., Cao, J., Huang, K., Huang, C., Zhao, Q., & Qiu, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.4124 · Cited by 87
Qi, R., Wang, Y., Bruno, P. M., Xiao, H., Yu, Y., Li, T., Lauffer, S., Wei, W., Chen, Q., Kang, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02390-7 · Cited by 83
Rao, L., Wang, W., Meng, Q., Tian, M., Cai, B., Wang, Y., Li, A., Zan, M., Xiao, F., Bu, L., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03913 · Cited by 83
Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment
Shibata, A., Mcmullen, E., Pham, A. D., Belshan, M., Sanford, B. L., Zhou, Y., Goede, M., Date, A. A., & Destache, C. J. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0301 · Cited by 81
SMART drug delivery systems: Back to the future vs. clinical reality
Lammers, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.046 · Cited by 80
Liposomes containing Antiviral Antibody can protect Cells from Virus Infection
Magee, W. E., & Miller, O. V. (1972) · Nature · doi:10.1038/235339a0 · Cited by 75
Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
Yu, X., Zhang, S., Jiang, L., Cui, Y., Li, D., Wang, D., Wang, N., Fu, L., Shi, X., Li, Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13133 · Cited by 71
Cern, A., Marcus, D., Tropsha, A., Barenholz, Y., & Goldblum, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.015 · Cited by 70
Nanomaterial-Induced Autophagy: A New Reversal MDR Tool in Cancer Therapy?
Panzarini, E., & Dini, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500066v · Cited by 67
Look, M., Saltzman, W. M., Craft, J. E., & Fahmy, T. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.046 · Cited by 66
Steitz, J., Britten, C. M., Wölfel, T., & Tüting, T. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0042-5 · Cited by 65
Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EMPreprint
Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972927 · Cited by 59
Preparation and Efficacy of Newcastle Disease Virus DNA Vaccine Encapsulated in PLGA Nanoparticles
Zhao, K., Li, W., Huang, T., Luo, X., Chen, G., Zhang, Y., Guo, C., Dai, C., Jin, Z., Zhao, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082648 · Cited by 55
Kraft, J. C., McConnachie, L. A., Koehn, J., Kinman, L., Sun, J., Collier, A. C., Collins, C. J., Shen, D. D., & Ho, R. J. Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.003 · Cited by 49
Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis
Liu, L., Ren, J., He, Z., Men, K., Ye, M., Ye, T., Chen, H., Li, L., Xu, B., Wei, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11450-3 · Cited by 48
Hobson, J., Al‐khouja, A., Curley, P., Meyers, D. J., Flexner, C. W., Siccardi, M., Owen, A., Meyers, C. L. F., & Rannard, S. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09354-z · Cited by 43
A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China.
Wu, W., Wang, J., Liu, P., et al. (2003) · PubMed · Cited by 41
Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
Jayant, R. D., Tiwari, S., Atluri, V. S. R., Kaushik, A. K., Tomitaka, A., Yndart, A., Colón-Pérez, L. M., Febo, M., & Nair, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31285-w · Cited by 37
Zhong, H., Mu, J., Du, Y., Xu, Z., Xu, Y., Yu, N., Zhang, S., & Guo, S. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01493 · Cited by 37
Hutnick, N. A., Myles, D. J. F., Ferraro, B., Lucke, C. E., Lin, F. W., Yan, J., Broderick, K. E., Khan, A. S., Sardesai, N. Y., & Weiner, D. B. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.055 · Cited by 32
Research Spotlight: Nanomedicines for HIV Therapy
Siccardi, M., Martin, P., McDonald, T. O., Liptrott, N. J., Giardiello, M., Rannard, S. P., & Owen, A. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.156 · Cited by 30
Smith, T. R. F., Schultheis, K., Morrow, M. P., Kraynyak, K. A., McCoy, J. R., Yim, K. C., Muthumani, K., Humeau, L. M. P. F., Weiner, D. B., Sardesai, N. Y., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.008 · Cited by 27
Kommareddy, S., Singh, M., & O’Hagan, D. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00013-x · Cited by 16
Ji, H., Yan, Y., Ding, B., Guo, W., Brunswick, M., Niethammer, A. G., SooHoo, W., Smith, R. A. J., Nahama, A., & Zhang, Y. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100026 · Cited by 15
Cited by
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 525
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
Pokrajac, L., Abbas, A., Chrzanowski, W., Dias, G. M., Eggleton, B. J., Maguire, S., Maine, E., Malloy, T., Nathwani, J., Nazar, L., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c10919 · Cited by 365
Towards safe and sustainable innovation in nanotechnology: State-of-play for smart nanomaterials
Gottardo, S., Mech, A., Drbohlavová, J., Małyska, A., Bøwadt, S., Riego Sintes, J., & Rauscher, H. (2021) · NanoImpact · doi:10.1016/j.impact.2021.100297 · Cited by 318
Theoretical basis for stabilizing messenger RNA through secondary structure design
Wayment-Steele, H. K., Kim, D. S., Choe, C. A., Nicol, J. J., Wellington-Oguri, R., Watkins, A. M., Sperberg, R. A. P., Huang, P.-S., Participants, E., & Das, R. (2020) · doi:10.1101/2020.08.22.262931 · Cited by 199
Metadata
- Authors
- Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-22
- Volume
- 14
- Issue
- 7
- Pages
- 7760-7782
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3036620193
- Cited by
- 385
- References
- 262
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.